COST-EFFECTIVENESS ANALYSIS OF FARICIMAB AND OTHERS TREATMENT SCHEMES FOR DIABETIC MACULAR EDEMA AND AGE-RELATED MACULAR DEGENERATION

被引：0
|
作者：
Figallo, M. [1 ]
Delgado, M. F. [2 ]
Ubaldo, E. [1 ]
机构：
[1] APOYO Consultoria, Lima, Peru
[2] London Sch Econ, London, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE488
引用
收藏
页码：S146 / S146
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of bispecific antibody faricimab for treatment of neovascular age-related macular degeneration and diabetic macular edema in Japan
    Yanagi, Yasuo
    Tsujimura, Jun
    Ohno, Shinya
    Higashi, Kentaro
    Sakashita, Naotaka
    Shoji, Ayako
    Igarashi, Ataru
    JOURNAL OF MEDICAL ECONOMICS, 2025, 28 (01) : 448 - 459
  • [2] Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
    Desideri, Lorenzo Ferro
    Traverso, Carlo Enrico
    Nicolo, Massimo
    Munk, Marion R.
    PHARMACEUTICS, 2023, 15 (05)
  • [3] Faricimab (Vabysmo) for Age-Related Macular Degeneration and Diabetic Macular Edema
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1646): : 45 - 46
  • [4] Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review
    Liberski, Slawomir
    Wichrowska, Malgorzata
    Kociecki, Jaroslaw
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [5] COST-EFFECTIVENESS OF FARICIMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CANADA
    Buhrer, C.
    Paulo, T.
    Diles, D.
    VALUE IN HEALTH, 2022, 25 (12) : S111 - S112
  • [6] Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Quah, Nicole Q. X.
    Javed, Khawaja Muhammad Ammar Ali
    Arbi, Lamees
    Hanumunthadu, Daren
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 1479 - 1490
  • [7] The cost-effectiveness of treatment of age-related macular degeneration: a review
    Kymes, Steven N.
    MINERVA MEDICA, 2009, 100 (01) : 69 - 77
  • [8] COST-EFFECTIVENESS OF FARICIMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA IN CANADA
    Buhrer, C.
    Paulo, T.
    Diles, D.
    VALUE IN HEALTH, 2022, 25 (12) : S140 - S140
  • [9] Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema
    Diack, Cheikh
    Avery, Robert L.
    Cheung, Chui Ming Gemmy
    Csaky, Karl G.
    Gibiansky, Leonid
    Jaminion, Felix
    Gibiansky, Ekaterina
    Sickert, Denise
    Stoilov, Ivo
    Cosson, Valerie
    Bogman, Katrijn
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2024, 13 (11):
  • [10] Treatment Approaches for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Almony, Arghavan
    AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (06): : S81 - S89
12345